Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/9/11 → 3/9/14 |
Funding
- PRA Health Sciences (GS-US-196-0140)
- Gilead Sciences, Inc. (GS-US-196-0140)
Prot # GS-US-196-0140: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating 16 and 24 Weeks of a Four-Drug Regimen and 24 Weeks of a Three-Drug Regimen of GS-9451, Peginterferon Alfa 2a(PEG, Pegasys) and Ribavirin (RBV, Copegus) with
- Flamm, Steven L (PD/PI)
- Ganger, Daniel R (Co-Investigator)
Project: Research project